Examkin

Question

Difficulty: HardBreast Disorders

A 44-year-old woman comes to the clinic after noticing a new lump in her right breast 2 weeks ago. She performs intermittent breast self-examinations and has no family history of breast or ovarian cancer. Her medical history is significant for primary hypothyroidism, for which she takes levothyroxine. Menarche was at age 12, and she has regular menstrual cycles. She had a routine screening mammogram 4 months ago, which was reported as normal with heterogeneously dense breast tissue (BI-RADS 1). Vital signs are within normal limits. On physical examination, there is a 2.5-cm, firm, non-tender, and freely mobile mass in the upper outer quadrant of the right breast. There are no overlying skin changes, nipple retraction, or nipple discharge. There is no palpable cervical, supraclavicular, or axillary lymphadenopathy. Which of the following is the most appropriate next step in management?

  1. A
    Targeted ultrasound of the right breast
  2. Diagnostic mammography and targeted ultrasoundAnswer
  3. C
    Core needle biopsy
  4. D
    Breast magnetic resonance imaging
  5. E
    Reassurance and repeat examination in 6 months

Answer

The most appropriate next step is diagnostic mammography and targeted ultrasound.
The correct answer is diagnostic mammography and targeted ultrasound. For any woman aged 30 or older who presents with a newly identified palpable breast mass, standard clinical guidelines dictate that both targeted ultrasound and diagnostic mammography must be performed. A screening mammogram is designed for asymptomatic patients and utilizes only two standard views (craniocaudal and mediolateral oblique). In contrast, a diagnostic mammogram employs additional, specialized views (such as spot compression or magnification) specifically focused on the palpable abnormality. Furthermore, screening mammography has a false-negative rate of up to 15%, which is even higher in patients with dense breast tissue. Therefore, a recent 'normal' screening mammogram provides false reassurance and does not bypass the need for a complete diagnostic imaging workup when a new focal finding arises.

Step-by-Step Solution

1
Identify the patient's demographic and clinical presentation.
The patient is a 44-year-old woman presenting with a new, 2.5-cm, firm, palpable breast mass.
Age and the presence of a focal palpable mass are the primary determinants of the initial diagnostic pathway in breast pathology.
2
Evaluate the significance of the previous imaging.
The screening mammogram from 4 months ago was normal, but the patient now has a new, clinically apparent mass.
Screening mammograms consist of only two standard views per breast and can miss up to 15% of breast cancers, particularly in patients with dense breast tissue. A prior negative screening mammogram does not preclude the need for a full diagnostic workup of a new symptom.
3
Apply the age-based algorithm for a palpable breast mass.
Because the patient is ≥ 30 years old, the standard of care requires both a targeted ultrasound and a diagnostic mammogram.
Diagnostic mammography includes specialized views (e.g., spot compression, magnification) tailored to the palpable area and evaluates the rest of the breast tissue. Ultrasound characterizes the mass (cystic vs. solid) and guides potential biopsy. Both are mandatory in this age group.

Key Concept

In women aged 30 years or older presenting with a new palpable breast mass, the most appropriate initial evaluation is diagnostic mammography and targeted ultrasound, even if a recent screening mammogram was normal.
Rate this question

Topics

Breast Disorders

More questions from this topic